相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Bart O. Roep et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
Matthias von Herrath et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the US
Vibha Anand et al.
DIABETES CARE (2021)
Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes
Paolo Pozzilli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Decreased Incidence of Type 1 Diabetes in Young Finnish Children
Anna Parviainen et al.
DIABETES CARE (2020)
Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?
Roberto Mallone et al.
DIABETOLOGIA (2020)
Liraglutide in Children and Adolescents with Type 2 Diabetes
William V. Tamborlane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Biomarkers of islet beta cell stress and death in type 1 diabetes
Emily K. Sims et al.
DIABETOLOGIA (2018)
The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update
Marian Rewers et al.
CURRENT DIABETES REPORTS (2018)
Understanding and preventing type 1 diabetes through the unique working model of TrialNet
Manuela Battaglia et al.
DIABETOLOGIA (2017)
Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis
Zin Z. Htike et al.
DIABETES OBESITY & METABOLISM (2017)
Reduced β-cell function in early preclinical type 1 diabetes
Maarit K. Koskinen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel et al.
DIABETES CARE (2015)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
David J. Klein et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2014)
Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
Anette G. Ziegler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial-Type 1
Jay M. Sosenko et al.
DIABETES (2012)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2010)
Glucagon-Like Peptide-1 Agonists Protect Pancreatic β-Cells From Upotoxic Endoplasmic Reticulum Stress Through Upregulation of BiP and JunB
Daniel A. Cunha et al.
DIABETES (2009)
New Definition for the Partial Remission Period in Children and Adolescents with Type 1 Diabetes
Henrik B. Mortensen et al.
DIABETES CARE (2009)
Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
Carla J. Greenbaum et al.
DIABETES CARE (2008)
Exendin-4 modulates diabetes onset in nonobese diabetic mice
Irene Hadjiyanni et al.
ENDOCRINOLOGY (2008)
Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
Kirsti Nanto-Salonen et al.
LANCET (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
分享论文
